Search filters

List of works by Anthony V D'Amico

10-Year Outcomes in Localized Prostate Cancer

scientific article published on 12 January 2017

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

scientific article

A Bayesian multi-risks survival (MRS) model in the presence of double censorings

scientific article published on 28 January 2020

A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer

scientific article published on 10 January 2019

A comparative study of rectal dose histograms in prostate brachytherapy: some analytic and numerical results

scientific article

A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization

scientific article published on 11 April 2006

A systematic review of hypofractionation for primary management of prostate cancer

scientific article

ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.

scientific article published on 20 March 2017

ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer

scientific article published on 22 December 2013

ACR Appropriateness Criteria® Definitive External-Beam Irradiation in stage T1 and T2 prostate cancer

scientific article

ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer

scientific article published on 4 January 2017

ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.

scientific article

ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.

scientific article

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer

scientific article

Academic career selection and retention in radiation oncology: the Joint Center for Radiation Therapy experience

scientific article published on 2 February 2007

Accurate Gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists

scientific article published in August 2003

Active Surveillance Versus Treatment of Prostate Cancer: Should Metastasis Be the Primary End Point?

scientific article published on 27 February 2017

Active Surveillance for Low-Risk Prostate Cancer in Black Patients

scientific article published on 01 May 2019

Activities and accomplishments of the cancer and leukemia group B genitourinary committee.

scientific article

Acute gastrointestinal, genitourinary, and dermatological toxicity during dose-escalated 3D-conformal radiation therapy (3DCRT) using an intrarectal balloon for prostate gland localization and immobilization

scientific article published in June 2005

Acute urinary retention after magnetic resonance image-guided prostate brachytherapy with and without neoadjuvant external beam radiotherapy

scientific article published in April 2005

Adjuvant Versus Salvage Post-Prostatectomy Radiation Therapy: A Critical Review of the Evidence ⬇️

scientific article published on May 18, 2013

Adjuvant and Salvage Radiation Therapy After Prostatectomy: ASTRO/AUA Guideline Amendment, Executive Summary 2018

scientific article published on 30 April 2019

Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO/AUA Guideline Amendment 2018-2019

scientific article published on 08 August 2019

Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database

scientific article published on 01 July 2007

Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death

scientific article published in December 2010

Adjuvant vs Salvage Radiation Therapy for High-Risk Prostate Cancer Following Radical Prostatectomy

scientific article published on 11 June 2020

Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma

scientific article published on 01 January 2003

Advancing Age and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men with Gleason Score 6 Prostate Cancer

scientific article published on 05 August 2019

Advancing age within established Gleason score categories and the risk of prostate cancer‐specific mortality (PCSM) ⬇️

scientific article published on October 1, 2012

Adverse effects of androgen deprivation therapy and strategies to mitigate them.

scientific article

Age, Comorbidity, and the Risk of Prostate Cancer-Specific Mortality in Men With Biopsy Gleason Score 4+3: Implications on Patient Selection for Multiparametric MRI

scientific article published on 17 March 2015

Alcohol Use Among Patients With Cancer and Survivors in the United States, 2000-2017

scientific article published on 01 January 2020

American Cancer Society guideline for the early detection of prostate cancer: update 2010

scientific article

An image contrast agent selectively activated by prostate specific antigen

scientific article published on 26 September 2005

Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality

scientific article

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease

scientific article published on 29 April 2015

Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality

scientific article published on 09 October 2007

Androgen deprivation therapy use and risk of death in men treated with high-dose radiation for intermediate-risk prostate cancer

scientific article published on 18 May 2016

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

scientific article published on January 2008

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

scientific article

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

scientific article

Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke

scientific article published on 4 March 2010

Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps m

scientific article published on July 2010

Aspirin and hormone therapy for prostate cancer

scientific article published in December 2007

Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy

scientific article

Assessing a Prostate Cancer Brachytherapy Technique Using Early Patient-Reported Symptoms: A Potential Early Indicator for Technology Assessment?

scientific article published on 01 June 2004

Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance

scientific article published on 01 November 2020

Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer

scientific article published on 01 June 2018

Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer

scientific article published on 01 April 2020

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

scientific article published on 13 November 2019

Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer

scientific article published on 01 June 2019

Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.

scientific article published on 15 August 2014

Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.

scientific article published in September 2010

Author Reply

Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era

scientific article published on 01 July 2002

Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer

scientific article published on 01 December 2008

Biological in situ dose painting for image-guided radiation therapy using drug-loaded implantable devices

scientific article published on 30 October 2009

Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: an update prologue

scientific article published on June 2004

Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade.

scientific article published on 4 May 2012

Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.

scientific article published on 21 December 2017

Can short-term hormone therapy for rising PSA prolong survival?

scientific article published on 06 May 2016

Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?

scientific article published on 01 March 2003

Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015

scientific article published on 03 May 2019

Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer

scientific article published on 01 December 2006

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

scientific article published in June 2003

Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer

scientific article published on 01 June 2019

Cardiovascular Comorbidity and Mortality in Men With Prostate Cancer Treated With Brachytherapy-Based Radiation With or Without Hormonal Therapy ⬇️

scientific article published on January 16, 2013

Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer

scientific article

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

scientific article published in December 2008

Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer

scientific article published on 30 October 2009

Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era

scientific article published on 01 October 2002

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study

scientific article published on 05 April 2018

Clinical decisions. Screening for prostate cancer

scientific article published on August 2012

Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA <or=10, and clinically localized prostate cancer

scientific article published in January 2003

Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer

scientific article published on 01 July 2002

Clinicopathologic and Molecular Characteristics of Prostate Cancer Diagnosed in Young Men Aged up to 45 Years

scientific article published on 11 December 2020

Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer

scientific article published on 09 October 2019

Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials

scientific article published on 03 September 2008

Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial ⬇️

scientific article published on February 1, 2011

Comorbidity and the Receipt of Curative Therapy for Favorable-risk Prostate Cancer Prior to and Following the Publication of PIVOT

scientific article published on 03 March 2016

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence

scientific article published on 01 February 2010

Comparative effectiveness of minimally invasive vs open radical prostatectomy.

scientific article published on October 2009

Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate

scientific article published on 01 December 2003

Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794.

scientific article published on 11 October 2012

Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer.

scientific article published on 6 April 2015

Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database

scientific article published on 28 June 2019

Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Meta-analysis of Randomized Noninferiority Trials

scientific article published on 4 November 2017

Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer ⬇️

scientific article published on July 23, 2011

Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation ⬇️

scientific article published on August 31, 2010

Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysis.

scientific article published on 7 February 2013

Deciding which patients to treat with salvage radiotherapy after prostatectomy.

scientific article

Decipher Postprostatectomy: Is It Ready for Clinical Use?

scientific article published on 30 March 2017

Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer

scientific article published on 01 November 2007

Defining a standard set of patient-centered outcomes for men with localized prostate cancer

scientific article

Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial

scientific article

Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate.

scientific article published on 29 October 2007

Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men.

scientific article published on 16 August 2010

Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer

scientific article published on 01 December 2002

Diabetes Mellitus, Race and the Odds of High Grade Prostate Cancer in Men Treated With Radiation Therapy ⬇️

scientific article published on October 22, 2011

Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopes

scientific article published on 02 August 2013

Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer

article

Duration of testosterone suppression and the risk of death from prostate cancer in men treated using radiation and 6 months of hormone therapy

scientific article published in October 2007

Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer-Specific Mortality

scientific article published on 01 June 2018

Early detection of high‐grade prostate cancer using digital rectal examination (DRE) in men with a prostate‐specific antigen level of &lt;2.5 ng/mL and the risk of death ⬇️

scientific article published on July 3, 2012

Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial

scientific article published on 01 January 2007

Effect of definition of preradiotherapy prostate-specific antigen velocity on its association with prostate cancer-specific mortality and all-cause mortality

scientific article published on 01 August 2007

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen

scientific article published on July 2003

Eighteen Months of Androgen Deprivation Therapy in Men with High-risk Prostate Cancer and the Risk of Death

scientific article published on 02 July 2018

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

scientific article

Enabling hope

scientific article published on 01 December 2020

Erectile function outcome reporting after clinically localized prostate cancer treatment

scientific article

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort

scientific article published on 16 April 2014

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence

scientific article published on 26 October 2009

Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy

scientific article published on 10 January 2019

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

scientific article published on 18 June 2020

Everything Happens for a Reason

scientific article published on 19 July 2019

Evidence suggesting that obesity prevention measures may improve prostate cancer outcomes using data from a prospective randomized trial

scientific article

Evidence to support a continued stage migration and decrease in prostate cancer specific mortality

scientific article published on 01 March 2006

Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era

scientific article published on 01 September 2002

Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer

scientific article published on 27 October 2020

FOAM ROLLING AND INDICES OF AUTONOMIC RECOVERY FOLLOWING EXERCISE-INDUCED MUSCLE DAMAGE

scientific article published on 01 May 2020

Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment

scientific article

Future of Treatment for Low-Risk Prostate Cancer: For All, for Some, or for None? ⬇️

scientific article published on April 4, 2011

Gene expression correlates of clinical prostate cancer behavior

article

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.

scientific article published on 17 May 2014

Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials

scientific article published on 7 January 2009

Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death

scientific article published on 17 September 2015

Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy

scientific article published on January 2007

Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy

scientific article published on 05 March 2015

Greatest percentage of involved core length and the risk of death from prostate cancer in men with highest Gleason score ≥ 7

scientific article published on 04 February 2014

Guideline for the management of clinically localized prostate cancer: 2007 update.

scientific article

Hormonal Therapy or External-Beam Radiation With Brachytherapy and the Risk of Death From Prostate Cancer in Men With Intermediate Risk Prostate Cancer ⬇️

scientific article published on November 29, 2011

Hormonal therapy and radiation for prostate cancer: is it safe?

scientific article published in July 2010

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction

scientific article published on 01 August 2009

How to compare results after surgery or radiation for localized prostate carcinoma

scientific article published on 01 November 2002

Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer

scientific article published on 04 May 2013

Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer

scientific article published in December 2006

Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure

scientific article published on 01 August 2005

Image contrast agents activated by prostate specific antigen (PSA).

scientific article published in June 2004

Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level

scientific article

Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy

scientific article published on 01 August 2005

Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate cancer.

scientific article

Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death

scientific article published in April 2010

Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate

scientific article published on 01 June 2002

Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patients

scientific article published on 01 November 2005

Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease

scientific article published in September 2004

Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.

scientific article published on 16 January 2018

Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy

scientific article published in May 2004

In reply to Froehner et al

scientific article published on 01 November 2013

Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer

scientific article published on 08 February 2020

Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction

scientific article published on 25 June 2011

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

scientific article published on 01 June 2007

Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone

scientific article published on 11 March 2016

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

scientific article published on 01 April 2007

Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma

scientific article

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

scientific article

Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer

scientific article

Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference

article

Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure

scientific article

Intermediate-risk Prostate Cancer: Stratification and Management

scientific article published on 14 April 2020

Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.

scientific article published on 22 April 2009

Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors

scientific article published in February 2004

Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?

scientific article

Is long-term androgen suppression right for everyone with locally advanced prostate cancer? ⬇️

scientific article published on October 7, 2010

Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?

scientific article published on 01 May 2008

Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis

scientific article published on 01 August 2002

Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy

scientific article published in September 2003

Localization of a portion of an endorectal balloon for prostate image-guided radiation therapy using cone-beam tomosynthesis: a feasibility study

scientific article published on 6 March 2012

Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer

scientific article

Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer

scientific article published on 05 July 2018

Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation

scientific article

Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.

scientific article published on 20 December 2017

Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less

scientific article published in May 2002

Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer disease

scientific article published in January 2010

Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study

scientific article published on 01 October 2007

Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer

scientific article published on 01 December 2005

Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature

scientific article published on 16 May 2013

Mathematical rigor is necessary, but for men with prostate cancer, clinical relevance is the priority

scientific article published on 23 February 2009

Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer

scientific article published on 01 November 2005

Maximum tumor diameter and the risk of prostate-specific antigen recurrence after radical prostatectomy

scientific article published on 28 March 2014

Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy

scientific article published on 23 February 2009

Models of care and NCCN guideline adherence in very-low-risk prostate cancer.

scientific article

Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy

scientific article published in February 2010

Motion and shape change when using an endorectal balloon during prostate radiation therapy

scientific article published on 27 October 2006

Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer.

scientific article

NCCN clinical practice guidelines in oncology: prostate cancer

scientific article

Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators

scientific article published on 20 February 2014

Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary Artery Disease ⬇️

scientific article published on 07 September 2012

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer

scientific article

Operating characteristics of prostate-specific antigen and verification bias

scientific article

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer

scientific article

PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.

scientific article published in October 2007

PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level

scientific article published on 01 September 2005

PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness

scientific article published on 24 June 2008

Patient and treatment factors associated with complications after prostate brachytherapy

scientific article

Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature

scientific article published on October 2007

Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy

scientific article published on 01 July 2005

Patient-reported quality of life after salvage brachytherapy for radio-recurrent prostate cancer: A prospective Phase II study

scientific article published on 9 May 2009

Patient‐reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial ⬇️

scientific article published on April 13, 2012

Pelvis Plus Prostate Radiation Therapy and the Risk of Death in Men With Newly Diagnosed Node-Positive Prostate Cancer

scientific article published on 25 November 2015

Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?

scientific article published on 01 May 2002

Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer

scientific article published on 09 June 2006

Personalizing the Management of Men with Intermediate-risk Prostate Cancer ⬇️

scientific article published on March 26, 2013

Personalizing the Use of Active Surveillance As an Initial Approach for Men With Newly Diagnosed Prostate Cancer

scientific article published on 31 August 2015

Personalizing the duration of androgen-deprivation therapy use in the management of intermediate-risk prostate cancer

scientific article published on 22 December 2014

Population-based determinants of radical prostatectomy surgical margin positivity.

scientific article published on 13 October 2010

Post-Prostatectomy Radiation Therapy: Balancing Disease Control and Functional Outcomes

scientific article published on 16 December 2016

Post-operative salvage androgen deprivation and radiotherapy for prostate cancer

scientific article published on 16 October 2019

Posttreatment Prostate Specific Antigen Nadir Predicts Prostate Cancer Specific and All Cause Mortality

scientific article published on 11 April 2012

Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer

scientific article published on 01 March 2007

Predicting Life Expectancy in Men Diagnosed with Prostate Cancer

scientific article

Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database

scientific article published on 3 December 2007

Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors

scientific article published on 07 August 2008

Predicting prostate-specific antigen recurrence established: now, who will survive?

scientific article published on 01 August 2002

Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era.

scientific article published on 13 March 2009

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer.

scientific article published in September 2002

Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer

scientific article published on 01 August 2006

Predictors of mortality after prostate-specific antigen failure

scientific article published on 06 May 2006

Predictors of patient preferences and treatment choices for localized prostate cancer

scientific article published on 01 October 2008

Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy

scientific article published on 01 October 2005

Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy

scientific article published on 08 September 2009

Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era

scientific article published on 01 March 2005

Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice

scientific article published on 24 February 2011

Preoperative 3-Tesla Multiparametric Endorectal Magnetic Resonance Imaging Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer ⬇️

scientific article published on October 3, 2012

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

scientific article

Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer

scientific article published on 01 February 2006

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

scientific article published on 01 July 2005

Pretreatment predictors of posttreatment PSA doubling times for patients undergoing three-dimensional conformal radiotherapy for clinically localized prostate cancer

scientific article published on 01 November 2005

Pretreatment predictors of time to cancer specific death after prostate specific antigen failure

scientific article

Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer

scientific article published on 8 June 2009

Prior-cancer diagnosis in men with nonmetastatic prostate cancer and the risk of prostate-cancer-specific and all-cause mortality

scientific article published on 30 January 2014

Probiotic use and clindamycin-induced hypercholesterolemia.

scientific article

Progress and controversies: Radiation therapy for prostate cancer

scientific article

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 May 2019

Prostate Cancer: Where We Have Been, Where We Are, and Where We Are Going ⬇️

scientific article published on July 1, 2013

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time

scientific article published on 18 April 2008

Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012

scientific article published on 03 December 2019

Prostate cancer prevention and finasteride

scientific article published on November 2006

Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy

scientific article published on 17 March 2010

Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors

scientific article published on 01 July 2007

Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer

scientific article published on 01 June 2010

Prostate cancer. Clinical practice guidelines in oncology

scientific article

Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy

scientific article published on 01 November 2004

Prostate specific antigen kinetics in the management of prostate cancer.

scientific article published on 25 January 2008

Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial

scientific article published on 6 September 2016

Prostate-Specific Antigen Velocity Before and After Elimination of Factors That Can Confound the Prostate-Specific Antigen Level ⬇️

scientific article published on 02 June 2011

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis

scientific article published on 13 April 2019

Prostate-specific antigen (PSA) and PSA velocity: competitors or collaborators in the prediction of curable and clinically significant prostate cancer

scientific article published in February 2008

Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer

scientific article published on June 2004

Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response

scientific article published on 01 August 2007

Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure

scientific article published on 01 September 2005

Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer

scientific article published on 01 November 2006

Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer

scientific article

Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma

scientific article published on 01 January 2006

Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer

scientific article published on 01 November 2007

Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality

scientific article published in August 2006

Provider Case Volume and Outcomes Following Prostate Brachytherapy

scientific article published on 13 November 2008

Quantifying the change in endorectal magnetic resonance imaging-defined tumor volume during neoadjuvant androgen suppression therapy in patients with prostate cancer

scientific article published on 01 September 2003

Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer

scientific article

Quantitative MR Imaging Assessment of Prostate Gland Deformation before and During MR Imaging–Guided Brachytherapy

article

Race and Survival Following Brachytherapy-Based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate ⬇️

scientific article published on April 20, 2011

Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer.

scientific article published on 4 August 2016

Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.

scientific article published on 23 May 2014

Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer

scientific article published on 9 May 2014

Radiation Therapy for Prostate Cancer

scientific article published on 28 October 2019

Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer—Reply

scientific article published in The Journal of the American Medical Association

Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer

scientific article

Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group

scientific article published on 26 October 2009

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

scientific article published in March 2018

Radical prostatectomy for high-grade prostate cancer

scientific article published on 01 August 2006

Radical prostatectomy vs radiation therapy and androgen‐suppression therapy in high‐risk prostate cancer ⬇️

scientific article published on April 30, 2012

Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s).

scientific article published on 29 March 2010

Re: Early detection of prostate cancer: AUA guideline: H. B. Carter, P. C. Albertsen, M. J. Barry, R. Etzioni, S. J. Freedland, K. L. Greene, L. Holmberg, P. Kantoff, B. R. Konety, M. H. Murad, D. F. Penson and A. L. Zietman J Urol 2013; 190: 419-42

scientific article published on 17 July 2013

Re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96

scientific article published on 28 August 2020

Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials

scientific article published on 12 November 2010

Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone

scientific article published on January 2013

Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic

scientific article published on 13 August 2020

Reply to D.E. Spratt

scientific article published on 06 July 2017

Reply to K. Quan et Al, S.P. Collins et al, C.R. King et al, s. Arcangeli et al, d.B. Fuller, and D. Vordermark

scientific article published on 02 September 2014

Reply to M.C. Scholz et al

scientific article published on 16 February 2016

Reply to Partial gland therapy for prostate cancer

scientific article published on 20 December 2018

Response to Drs Rogers, Hayes, and Demanes

scientific article published on 28 May 2014

Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer

scientific article published on June 2015

Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease ⬇️

scientific article published on May 14, 2011

Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size

scientific article published on 3 June 2010

Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease

scientific article published on 13 July 2009

Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy

scientific article published in June 2008

Risk-Based Management of Prostate Cancer ⬇️

scientific article published on July 14, 2011

Salvage radiation in men after prostate-specific antigen failure and the risk of death

scientific article

Screening for familial and hereditary prostate cancer

scientific article published on 5 December 2015

Screening for prostate carcinoma: prostate-specific antigen--friend or foe?

scientific article published on 01 March 2005

Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events

scientific article published in December 2002

Sequencing Treatments for Cancer During the COVID-19 Pandemic

scientific article published on 27 May 2020

Short- vs long-term androgen suppression plus external beam radiation therapy and survival in men of advanced age with node-negative high-risk adenocarcinoma of the prostate

scientific article published on 01 May 2007

Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy

scientific article published on 8 September 2015

Should all colorectal cancer patients over age 60 be screened for prostate cancer?

scientific article published in October 2013

Six-month androgen suppression plus radiation therapy compared with radiation therapy alone for men with prostate cancer and a rapidly increasing pretreatment prostate-specific antigen level

scientific article published on 01 September 2006

Statin use and the risk of prostate-specific antigen recurrence after radiation therapy with or without hormone therapy for prostate cancer

scientific article

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: less cost at the expense of more genitourinary toxicity is a concerning but testable hypothesis

scientific article published on 10 March 2014

Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality

scientific article published on 01 February 2019

Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 12 January 2017

Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer

scientific article published on 01 May 2005

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

scientific article published in September 2003

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

article

Survival Following Radiation and Androgen Suppression Therapy for Prostate Cancer in Healthy Older Men: Implications for Screening Recommendations

scientific article published on 22 April 2009

Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials

scientific article published on 01 April 2008

The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.

scientific article

The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer

scientific article published on 08 July 2009

The Effect of Foam Rolling on Recovery Between two Eight Hundred Metre Runs

scientific article published on 22 June 2017

The Impact of Economic Recession on the Incidence and Treatment of Cancer

scientific article published on 24 June 2015

The Number of High-Risk Factors and the Risk of Prostate Cancer–Specific Mortality After Brachytherapy: Implications for Treatment Selection ⬇️

scientific article published on January 31, 2012

The effect of differing Gleason scores at biopsy on the odds of upgrading and the risk of death from prostate cancer

scientific article published on 3 March 2014

The impact of PSA and digital rectal examination on the risk of prostate cancer specific mortality in men with a PSA level <2.5 ng/ml

scientific article published on 19 August 2014

The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate carcinoma

scientific article

The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate

scientific article published in July 2004

The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis

scientific article published on 01 August 2008

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease

scientific article published on 06 March 2014

The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement

scientific article published on 01 April 2010

Therapeutic strategies for localized and locally advanced prostate cancer: combining androgen suppression with definitive local therapy

scientific article published on 01 January 2003

Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment

scientific article published on December 2003

Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy

scientific article published on 04 May 2018

Time course and predictors of symptoms after primary prostate cancer therapy

scientific article

Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy

scientific article published on 18 January 2019

Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality

scientific article published on 01 April 2007

Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality

scientific article published on 01 January 2008

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

scientific article published on March 2009

Timing of radiotherapy after radical prostatectomy

scientific article published on 28 September 2020

Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.

scientific article published on 18 June 2009

Toward personalizing the use of androgen deprivation therapy to maximize benefit and minimize harm

scientific article published on 23 December 2014

Toward the optimal use of androgen suppression therapy in the radiotherapeutic management of prostate cancer

scientific article published on 01 January 2007

Treatment or Monitoring for Early Prostate Cancer

scientific article published on 14 September 2016

Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups

scientific article

Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study

scientific article

Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer ⬇️

scientific article published on September 21, 2011

US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.

scientific article published on 16 December 2013

Unfavorable Intermediate-Risk Prostate Cancer and the Odds of Upgrading to Gleason 8 or Higher at Prostatectomy

scientific article published on 16 June 2016

Updated Results of Magnetic Resonance Imaging Guided Partial Prostate Brachytherapy for Favorable Risk Prostate Cancer: Implications for Focal Therapy ⬇️

scientific article published on August 15, 2012

Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015

scientific article published on 01 February 2019

Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results

scientific article published on 28 May 2014

Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy

scientific article published on 01 July 2002

Using patient-reported outcomes to assess and improve prostate cancer brachytherapy

scientific article published on 22 May 2014

Using prostate-specific antigen doubling time in clinical practice

scientific article published on 19 May 2007

Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce

scientific article published on 01 November 2002

Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy

scientific article

Utilization of multimodality therapy with primary radical prostatectomy versus radiation therapy for Gleason 8-10 prostate cancer

scientific article published on 29 October 2020

Validity of Surrogate End Points for Prostate Cancer-Reply

scientific article published on 31 August 2017

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

scientific article published on 01 February 2007

Volume of Gleason Pattern 4 Stratifies Risk of Metastasis and Death in Patients with Gleason Score 3+5=8/5+3=8 Positive Prostate Core Biopsies

scientific article published on 11 March 2020

Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.

scientific article published on 31 December 2016

What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation ⬇️

scientific article published on July 17, 2012

When prostate brachytherapy fails: a case report and discussion

scientific article published in November 2005

Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy

scientific article published on 14 August 2010

Who bears the greatest burden of aggressive treatment of indolent prostate cancer?

scientific article published on 30 January 2015

Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk

scientific article published on May 2015

Workflow modeling and analysis of computer guided prostate brachytherapy under MR imaging control

scientific article published on 01 January 2004

p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).

scientific article

Paulina is supported by:

About Paulina

Help